Elevance Health will rate the clinical effectiveness of digital health products through a partnership with the Digital Medicine Society.
Elevance Health will assess clinical outcomes of digital health software through the Digital Medicine Society’s DiMe Seal program, according to a May 15 news release. The program rates digital products based on usability, privacy, security and clinical evidence.
The DiME Seal is designed to designate clinical quality for patient-facing digital health solutions, according to the program’s website.
“To improve health outcomes at scale, it is critical for the digital health industry to move in an evidence-based direction,” Jordan Silberman, MD, PhD, director of clinical analytics and research at Elevance, said.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
